Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings
© 2019 Wolters Kluwer Health, Inc. All rights reserved. Objective: HIV prevention and treatment studies demonstrate that pharmacologic adherence metrics are more accurate than self-report. Currently available metrics use liquid-chromatography/tandem-mass-spectrometry (LC-MS/MS), which is expensive a...
Saved in:
Main Authors: | Monica Gandhi, Guohong Wang, Roger King, Warren C. Rodrigues, Michael Vincent, David V. Glidden, Tim R. Cressey, Peter Bacchetti, Matthew A. Spinelli, Hideaki Okochi, Oraphan Siriprakaisil, Virat Klinbuayaem, Nelly R. Mugo, Kenneth Ngure, Paul K. Drain, Jared M. Baeten |
---|---|
Format: | Journal |
Published: |
2020
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85077226567&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/68432 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Brief Report: Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cutoff for a Point-of-Care Test
by: Monica Gandhi, et al.
Published: (2019) -
Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate
by: Tim R. Cressey, et al.
Published: (2020) -
Urine tenofovir concentrations correlate with plasma and relate to tenofovir disoproxil fumarate adherence: A randomized, directly observed pharmacokinetic trial (target study)
by: Paul K. Drain, et al.
Published: (2020) -
A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: The TARGET study
by: Tim R. Cressey, et al.
Published: (2018) -
A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: The TARGET study
by: Tim R. Cressey, et al.
Published: (2018)